Isomorphic Labs in talks to raise $5bn at a $50bn valuation, Bloomberg reports
· thenextweb.com · popularity 20/100 · 0 similar stories today · Future Technology, Innovation & Design (Discovery & Research)
Read the original at thenextweb.com →
Summary
Isomorphic Labs, the drug discovery company spun out of Google DeepMind, is in talks to raise about $5bn, Bloomberg reported on Wednesday. The round would put the Isomorphic Labs valuation at about $50bn, according to people familiar with the matter. The financing has not closed and the details could change, the people told Rebecca Torrence […] This story continues at The Next Web
Found in: The Next Web. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 5.